Literature DB >> 30711979

Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma.

Akira Watanabe1, Norihumi Harimoto2, Kenichiro Araki1, Norio Kubo1, Takamichi Igarashi1, Mariko Tsukagoshi1, Norihiro Ishii1, Takahiro Yamanaka1, Tomoharu Yoshizumi3, Ken Shirabe1.   

Abstract

BACKGROUND/AIM: Intrahepatic cholangiocarcinoma (IHCC) is characterized by poor prognosis, and postoperative recurrence remains a problem. Thus, prognostic markers for IHCC are greatly needed. Recently, inflammatory factors were reported to be related to tumor progression and recurrence in various cancers. Therefore, the present study aimed to evaluate the prognostic ability of inflammatory factors.
MATERIALS AND METHODS: Forty-four patients with mass-forming IHCC (m-IHCC) were retrospectively evaluated and the correlations between inflammatory markers, including neutrophil-to-lymphocyte ratio and, modified Glasgow prognostic score, and patient survival were assessed.
RESULTS: The absolute neutrophil count (ANC) was significantly higher in the recurrence group than in the non-recurrence group (p=0.00568) and the most significant prognostic factor by multivariate analysis. Poor recurrence-free survival (RFS; p=0.00452) and cancer-specific survival (CSS; p=0.0323) were associated with high neutrophil levels. Moreover, neutrophil infiltration in the tumor site was positively correlated with ANC.
CONCLUSION: ANC is associated with poor RFS, and could be used to predict recurrence in patients with m-IHCC. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Absolute neutrophil count; inflammation; intrahepatic cholangiocarcinoma

Mesh:

Year:  2019        PMID: 30711979     DOI: 10.21873/anticanres.13197

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Associations between absolute neutrophil count and lymphocyte-predominant breast cancer.

Authors:  Chang Ik Yoon; Soeun Park; Yoon Jin Cha; Hye Sun Lee; Soong June Bae; Chihwan Cha; Da Young Lee; Sung Gwe Ahn; Joon Jeong
Journal:  Breast       Date:  2019-10-03       Impact factor: 4.380

2.  Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients.

Authors:  Buwen Zhang; Weiyun Yao
Journal:  World J Surg Oncol       Date:  2022-09-29       Impact factor: 3.253

3.  Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.

Authors:  Qi Li; Yibo Shi; Rigai Sa; Jun Hao; Jinhao Hu; Mulun Xiao; Chaoliang Wang; Liang Yan; Baoping Qiao; Guoxun Chen
Journal:  BMC Cancer       Date:  2020-06-15       Impact factor: 4.430

4.  Therapeutic Outcomes and Prognostic Factors of Unresectable Intrahepatic Cholangiocarcinoma: A Data Mining Analysis.

Authors:  Tomotake Shirono; Takashi Niizeki; Hideki Iwamoto; Shigeo Shimose; Hiroyuki Suzuki; Takumi Kawaguchi; Naoki Kamachi; Yu Noda; Shusuke Okamura; Masahito Nakano; Ryoko Kuromatu; Hironori Koga; Takuji Torimura
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.